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Abstract
An ethanolic extract of Antiaris toxicaria trunk bark showed potent in vitro cardiotonic effect on
isolated guinea pig atria. Bioassay-guided fractionation of the extract led to identification of 9 new
cardiac glycosides (1–9, named antiarosides A-I), antiarotoxinin A (10), and 18 known
compounds. Their structures were established using MS and NMR spectroscopic studies,
including homonuclear and heteronuclear correlation experiments. The ability of these cardiotonic
compounds to produce positive inotropic action and their safety indexes were examined in
comparison with those of ouabain, a classical inhibitor of Na+/K+-ATPase. Malayoside (23) was
nearly equipotent and had a similar safety index to ouabain in guinea pig atria. However, the
maximal positive inotropic effect and safety index of 23 in papillary muscle were better than those
of ouabain. An electrophysiological recording showed that 23 inhibited sodium pump current in a
concentration-dependent manner.
Cardenolides are a group of C23 steroids produced in nature by several plant families and
some species of toads. Because a major site of their biological action is the heart,
cardenolide glycosides are also known as cardiac glycosides. These compounds share
common features of a steroidal aglycone linked at the 3β-OH group to one or more sugar
moieties. Some cardiac glycosides are highly toxic to humans and animals. Despite their
toxicity, certain glycosides have therapeutic effects and, at appropriate doses, have been
used in treatment of congestive heart failure. The only receptor for these compounds is the
integral membrane protein Na+/K+-ATPase. Cardiac glycosides inhibit Na+/K+-ATPase,
resulting in a positive inotropic effect at therapeutic doses, but also in cardiac arrhythmias
and death at toxic doses. Apart from their very widely known cardiotonic effects, cardiac
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glycosides may also inhibit cancer cell replication. Cardiac glycosides also act directly on
the gastrointestinal tract, causing hemorrhagic enteritis and diarrhea.
Antiaris toxicaria (Pers.) Lesch. (Moraceae), commonly known as upas tree, is a well known
toxic plant that is widely distributed throughout Malaysian forests. The latex of A. toxicaria,
called “Jianxiefenghou” in Chinese, has an unwarranted reputation for killing people who
fall asleep beneath it. It has been known for centuries that most poisoned darts used by
indigenous people of Southeast Asia are prepared by concentration of latex harvested from
A. toxicaria. Prey wounded by such an arrow can rarely move more than 100 meters. These
poisons act as powerful muscle relaxants to paralyze the prey, but have no effect when the
meat is eaten.1 Bisset reported that animals shot with poisoned darts “died with tetanic
convulsions,” indicating that A. toxicaria-derived poisons function through the bloodstream.
2 The notoriety of these materials prompted investigations of their constituents, and they
were found to be a good source of cardenolide cardiac glycosides.3–7 The active principles
were studied by Robinson and Ling, who observed cardiac irregularities and death when
extracts of A. toxicaria were injected into cats.8 Fujimoto et al. first found that cardiac
glycosides inhibited the activity of Na+/K+-ATPase.9
In the course of a drug-screening project on medicinal plants, an extract from the trunk bark
of A. toxicaria was found to have a strong cardiotonic effect. Bioassay-guided fractionation
led to the isolation and characterization of twenty-eight cardiac glycosides/aglycones,
including new compounds 1–10, designated as antiarosides A (1), B (2), C (3), D (4), E (5),
F (6), G (7), H (8), and I (9) and antiarotoxinin A (10). This study also evaluated the positive
inotropic effect and safety index of these compounds in guinea pig heart muscle. The goals
were to (a) find an effective and safe inotropic drug for improving hemodynamics in patients
with heart failure and (b) establish structure-activity relationships of cardiac glycosides.
Herein, we report the maximal positive inotropic effect and safety index of new compounds
1–10, as well as of known compounds 11–14 and 16–28, in guinea pig heart muscle. The
positive control was ouabain, a classical inhibitor of Na+/K+-ATPase.
Compd R1 R2 R3 R4
1 CH3 OH H β-O-β-D-antiarose
2 CH2OH H H β-O-α-L-rhamnosyl-(4→1)-β-D-glucose
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Compd R1 R2 R3 R4
3 CHO OH H α-O-α-L-rhamnose
4 CHO OH H α-O-α-L-rhamnosyl-(4→1)-β-D-glucose
5 COOH H H β-O-α-L-rhamnose
6 COOglc H H β-O-α-L-rhamnose
7 COOH OH OH β-O-α-L-rhamnose
8 COOH OH OH β-O-β-D-antiarose
9 H OH H β-O-α-L-rhamnose
23 CHO H H β-O-α-L-rhamnose
10
Results and Discussion
Fresh trunk bark of A. toxicaria was extracted with ethanol. The residue obtained after
evaporation of the ethanol extract was partitioned between CHCl3, n-BuOH, and H2O. The
CHCl3, n-BuOH and H2O soluble fractions were concentrated and the extracts were
individually subjected to column chromatography (CC) over silica gel and Diaion HP-20,
respectively. The subfractions obtained were examined by H2SO4 test solution spray on
TLC for cardiac glycosides, which show as green spots. The enriched cardiac glycoside
fractions were subjected to a series of column chromatographic steps (silica gel,
semipreparative reversed-phase HPLC, Sephadex LH-20) in order to obtain pure
cardenolides 1–28, which were characterized by analysis of their spectroscopic data.
Compound 1 had molecular formula C29H44O9, as established from HRFABMS ([M + Na]+
m/z 559.3063) and by the presence of 29 signals in the 13C NMR spectrum. The NMR
signals were due to three methyl, ten methylene, ten methine and six quaternary carbons as
determined using DEPT 135 spectroscopy (Table 1). Compound 1 showed a UV absorption
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maximum at 213 nm and IR absorption at 1738 cm−1 (γ-lactonic carbonyl), which were
indicative of a butenolactone system.10 The 1H NMR spectrum of 1 (Table 2) showed
characteristic signals of a butenolactone ring at δ 5.01 and 5.28 (each 1H, dd, J = 18.0, 1.3
Hz, H-21a and b) and δ 6.12 (s, H-22), and methyl singlets at δ 1.03 and 1.08 (each 3H, s,
H-18 and 19), indicating 1 to be a cardenolide with a C-19 methyl group. A doublet
anomeric proton at δ 5.37 (J = 8.1 Hz, H-1′), four oxymethine protons between δ 4.10 and
4.71 and a methyl signal at δ 1.56 (3H, d, J = 6.4 Hz), together with the fragment ion at m/z
373 in FABMS, pointed to the presence of a β-linked deoxyhexose unit (Table 1). The
deoxyhexose was concluded to be β-antiarose on the basis of 1H and 13C NMR data (Tables
1 and 2) and analyses of ROESY, COSY and HMQC experiments.7,11 The proton
resonating at δ 4.45 (H-2′), a double doublet (J = 8.1, 2.9 Hz), indicated an axial-axial
relationship to H-1′ and an axial-equatorial relationship to H-3′ (d, J = 2.9 Hz). Based on the
strong NOE effects between H-1′ and H-5′, both protons are in axial positions. Furthermore,
the measured JC1′-H1′ (157.6 Hz) for the anomeric axial proton is consistent with β-D
chemistry of the sugar moiety.12 Thus, based on the above data, the sugar moiety was
elucidated as β-D-antiarose. The aglycone was identified as periplogenin13 by analyses of
COSY, HMQC, HMBC and ROESY experiments and comparison to literature data. The
sugar unit was placed at C-3 on the basis of the glycosylation shifts of C-2 (δ 26.9), C-3 (δ
74.4), and C-4 (δ 34.5), and HMBC correlation between H-1′ of the antiarose unit and C-3
of the aglycone moiety. The β-orientation of antiarose at C-3 was deduced from the W1/2
constant of H-3 (br. s, W1/2 = 10.7 Hz). Thus, 1 was identified as periplogenin 3-O-β-
antiaropyranoside and was named antiaroside A.
The HRFAB mass spectrum of 2 showed a molecular ion-related [M + K]+ peak at m/z
737.8260, corresponding to the molecular formula C35H54O14. The 1H and 13C NMR data
(Tables 1 and 2) and fragment ions at m/z 519 and 356 in FABMS indicated 2 was a
cardenolide disaccharide with two hexose sugar units. Analyses of COSY, HMQC and
HMBC spectra indicated that the sugars were α-rhamnose and β-glucose with a (4-1)
linkage. The downfield shift of C-4′ of the rhamnose unit to δ 85.5, and C-1″ of the glucose
unit at δ 106.9, and an HMBC correlation between H-4′ and C-1″ confirmed the (4-1)
linkage between them. The 13C NMR spectrum (Table 2), combined with DEPT 135,
HMQC and HMBC experiments, of 2 indicated that the aglycone was cannogenol (15),
which was isolated from the CHCl3-soluble fraction. Location of the sugar unit at C-3 was
suggested by the downfield shift of C-3 from δ 66.1 in 15 to δ 72.7 in 2 and a HMBC
correlation between H-1′ and C-3. The β-orientation of the C-3 disaccharide unit was
deduced from the W1/2 constant of H-3 (br s, W1/2 = 13.6 Hz). Compound 2 was thus
assigned to be 3 β-[(O-β-glucopyranosyl(1-4)-α-rhamnopyranosyl)oxy]cannogenol, and it
was named antiaroside B.
Compound 3 showed a pseudo molecular ion peak at m/z 551.2855 in its HRFABMS and
had the same molecular formula as convallatoxin (17), C29H42O10. UV, IR, 1H, 13C NMR,
and MS spectroscopic analyses indicated that 3 was a stereoisomer of convallatoxin (17).
Downfield shifts of C-1, C-2, and C-6 from δ 18.7, 25.4, and 36.9 in 17 to δ 25.8, 26.0, and
42.8 in 3 indicated that the orientation of C-3 was different from that of 17. The α-
orientation of C-3 was deduced from the coupling constant values of H-3 (dddd, J = 11.2,
11.2, 5.0, 5.0 Hz). This assignment was supported by downfield shifts of H-2b, H-3, and H-4
from δ 2.00 (m), 4.32 (br. s, W1/2 = 8.3 Hz), 2.13 (d, J = 15.3 Hz), and 1.72 (m) in 17 to δ
2.29 (m), 4.66 (dddd, J = 11.2, 11.2, 5.0, 5.0 Hz), 2.42 (dd, J = 13.6, 4.3 Hz), and 1.78 (br.
d, J = 17.1 Hz) in 3. HMBC correlation of H-1′ with C-3 [ δC 72.5/δH 5.36 (br. s)], and NOE
correlation between H-3 and H-1′ inferred that the rhamnose unit was linked to C-3. Hence,
structure 3 was established for antiaroside C.
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Compound 4 was assigned molecular formula C35H52O15 by HRFABMS. Comparison of
the 1H and 13C NMR spectra of 4 with those of 3 showed that the two structures were very
similar, except for one additional sugar unit in 4. Based on its larger [M + K]+ ion at 751,
162 mass units more than that of 3, and appropriate sugar proton and carbon signals in the
NMR spectra, 4 has one glucosyl unit in addition to a rhamnosyl moiety. The H-1″ signal
appeared at δ 5.20 and showed HMBC correlation with the downfield shifted C-4′ (δ 85.1),
as well as NOE with H-4′. These data determined the interglycosydic linkage of the two
sugar moieties as α-rhamnosyl (4′-1′)-β-glucoside. A HMBC correlation between H-1′ and
C-3 (δ 72.5) suggested that the sugar unit was attached at C-3, and α-orientation was
deduced from the coupling type and constant values of H-3 (δ 4.69, dddd, J = 10.4, 10.4,
5.1, 5.1 Hz). Thus, the structure of 4 was deduced as 4′-O-β-glucopyranosyl antiaroside C
and was named antiaroside D.
Compound 5 had the same molecular formula as 17 (C29H42O10). Comparison of the 1H/13C
NMR spectra of 5 and 17 showed that the two structures were very similar, except for the
absence of signals for both an aldehyde and one oxygenated carbon in the former. A strong
carbonyl absorption in the IR spectrum at 1738 cm−1 and a carbon signal at δ 179.5 in
the 13C NMR spectrum suggested that a carboxylic acid rather than aldehyde group was
present at C-19. A proton signal at δ 2.92 (br. d, J = 12.6 Hz) in the 1H NMR was assignable
to H-5, since it coupled with H-4 and -6 in the COSY spectrum. Absence of a carbon signal
at δ 73.9 (C-5 in 17) and presence of a carbon signal at δ 32.8 (C-5 in 5) suggested that the
OH group on C-5 in 17 was not present in 5. This postulate was supported by upfield shifts
of C-4 and C-6 from δ 35.5 to δ 29.1 and δ 36.9 to δ 29.7, together with HMBC correlations
of H-3, 4b, 6b, and 7b to C-5. In a ROESY experiment, a correlation between H-5 and H-1b
(δ 3.29) determined β-orientation of H-5. An anomeric proton signal at δ 5.48 (br. s) and
carbon signals at δ 99.7, 73.0, 72.9, 74.1, 70.3, and 18.8 indicated the presence of a
rhamnosyl moiety. The HMBC correlation between H-3 and C-1′ placed the rhamnosyl unit
on C-3, and a W1/2 coupling constant of 12.4 Hz for H-3 indicated α-orientation. Therefore,
the structure 5 was established for antiaroside E.
Compound 6 (C35H52O15) had fragment ions at m/z 550 and 534 in the FABMS, and two
anomeric signals in the 1H/13C NMR spectra indicated that 6 was a diglycoside with β-
glucopyranose and α-rhamnose sugar units. The 1H and 13C NMR data of 6 were very close
to those of 5, except for the added signals of a glucopyranose moiety and the position of
C-19 (Tables 1 and 2). An anomeric proton signal at δ 6.29 (d, J = 8.0 Hz) in the 1H NMR
spectrum and signals at δ 95.7, 74.1, 79.1, 71.3, 79.4, and 62.5 in the 13C NMR spectrum
suggested the presence of β-glucose. The upfield shift of C-19 from δ 179.5 to δ 175.7, the
downfield shift of the anomeric proton to δ 6.29, and a 3J HMBC correlation from H-1″ to
C-19 suggested that the glucose unit was attached to C-19. Thus, the structure of 6 was
determined as 19-O-β-glucopyranosyl antiaroside E, and it was named antiaroside F.
Compound 7 (C29H42O12) was 16 mass units larger than β-antiarin (28),13 isolated from the
CHCl3 soluble fraction. The 1H and 13C NMR spectra of 7 were quite similar data to those
of 28, except for absence the aldehyde signal in 7. Thus, 7 was likely a 19-nor-β-antiarin
derivative. The major differences were that the proton signal at δ 10.37 (s) and the carbonyl
signal at δ 208.5 in 28 disappeared in 7, and instead one carboxyl carbon signal appeared at
δ 176.8. Thus, the aldehyde group of 28 was replaced by a carboxylic acid group in 7. This
conclusion was supported by strong IR absorption at 1726 cm−1. The β-orientations of OH
groups at C-3 and -12 were deduced from the coupling constants of H-3 (δ 4.35, br. s, W1/2
= 9.3 Hz), and H-12 (br. d, J = 10.8 Hz). On the basis of the above data, the structure of 7
was established, and it was named antiaroside G.
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Compound 8 had a molecular formula the same as that of 7 (C29H42O12). The UV, IR and
NMR data strongly resembled those of 7, consistent with a general structure containing a
central cardenolide moiety trioxygenated at C-3, C-5, and C-12 and a carboxylic acid group
in the 19-position. The sole significant differences observed were in signals of the glycosidic
part of the molecules (Tables 1 and 2). The sugar proton signals of 8 indicated the presence
of a β-antiarosyl moiety. These data were in agreement with the replacement of the
rhamnosyl unit in 7 by a antiarosyl unit in 8. The β-orientation of C-3 was deduced by the
W1/2 of H-3 (br. s, 12.1 Hz). Thus, structure of 8 was assigned, and it was named antiaroside
H.
A molecular formula of C28H42O9 was deduced for compound 9, 14 mass units less than
that of periplorhamnoside (11), which was isolated from the same extract. Comparison of
its 1H and 13C NMR data with those of 11 showed that they were similar except for the
absence of C-19 methyl group, the presence of one methine (-CH) at δ 1.83 (d, 12.5), and an
upfield shift of C-10 from δ 41.2 to δ 37.4 in 9. Thus, 9 was determined as
demethylperiplorhamnoside and it was named antiaroside I.
Compound 10 (C23H36O6) had 23 signals in the 13C NMR spectrum corresponding to two
methyl, eleven methylene, four methine, and six quaternary carbon atoms. The 1H and 13C
NMR spectra of 10 displayed signals characteristic of the steroid core of a cardenolide.
However, the absence of typical signals for the olefinic group of the butenolactone ring and
the downfield resonance of C-23 to 176.3, suggested that the carbonyl group of the five-
membered lactone in 10 was not conjugated with a double bond. This was confirmed by the
carbonyl absorption at 1761 cm−1 in the IR spectrum, the presence of two methylene groups
at δC 81.1/δH 4.78 and 4.40 (each 1H, d, J = 16.8 Hz, H-21) and δC 32.3/δH 2.86 and 2.82
(each 1H, d, J = 16.8 Hz, H-22) and the absence of any significant UV absorption. Three
OH groups were on the steroid skeleton (C-3, C-5, C-14) and a fourth OH group was placed
at C-20; this latter carbon resonated at δ 79.5 and no extra oxygenated signal, other than
aforementioned, was observed in the spectrum of 10. HMBC correlations from H-16, H-21b,
and H-22 to C-20 and from H-21b to C-22 confirmed the OH group at C-20. Orientation of
the C-3 OH was also determined by the W1/2 of H-3 (br s, 12.1 Hz). The above analysis
established the structure of 10 as shown, and the compound was named antiarotoxinin A.
Periplorhamnoside (11),13 cheiranthoside VII (12),11 strophanthidol (13),14 convallatoxol
(14),5 cannogenol (15),15 strophanthidin (16),13 convallatoxin (17),5 strophathojavoside
(18),16 desglucocheirotoxin (19),14 strophalloside (20),13 convalloside (21),17
glucostrophalloside (22),18 malayoside (23),5 antiarigenin (24),13 α-antiarin (25),5
antialloside (26),16 toxicarioside B (27),7 and β-antiarin (28)13 were also isolated from A.
toxicaria trunk bark. These known compounds were identified by comparison of their
physical and spectroscopic properties with those reported in the literature.
Minimal effective concentrations (PIECmin) to increase contraction of rat left atria were
0.05, 0.25, 1 and 7.5 μM for ouabain, 23, 16 and 8, respectively. In right ventricular muscle,
the PIECmin for the positive inotropic action of different cardiac glycosides varied from
0.075 μM to 8.33 μM (Table 3). Compounds with lower PIECmin may have stronger binding
affinity to Na+/K+-ATPase of cardiac muscle.
Maximal contractions after treatment with cardiac glycosides are expressed as a percentage
of those before glycoside treatment. For ouabain, 23, 16 and 8, these values were 775, 660,
165 and 144%, respectively, in left atria. In right ventricular muscle, the maximal
contractions were 249, 446, 240 and 260% compared to basal values for ouabain, 23, 16 and
8, respectively (Table 4).
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The safety index (therapeutic index) was calculated from the ratio of the arrhythmogenic
concentration to the minimal effective positively inotropic concentration. A narrow margin
of safety index restricts the therapeutic use of this class of positive inotropic drugs. For
example, the safety index of digitalis is narrow, and arrhythmias are common problems in
clinical practice.19 Safety indexes were 20, 20, 9 and 7.5 for ouabain, 23, 16 and 8,
respectively, in left atria. Safety indexes of ouabain, 23, 16 and 8 were 20, 24, 8.7 and 9.7,
respectively, in right ventricular muscle (Table 5).
Other compounds, such as 2 and 13, had larger safety indexes than ouabain and 23 (100 and
65 for 2 and 13 versus 20 and 24 for ouabain and 23). Maximal contractions after treatment
with 2 and 13 were 382 and 408%, respectively. In our previous study, we found that 23 had
a larger safety index than ouabain in vivo.20 Whether 2 and 13 have better safety indexes
than ouabain or 23 in animals remains to be determined.
The following structure-activity relationships were identified in these studies. Changing the
β-O-α-rhamnose in 7 to β-O-β-antiarose in 8 increased PIECmin in atria from 3.75 μM to 7.5
μM and in right ventricular muscle from 3.67 μM to 8.33 μM (Table 3). Comparison of 3
with one sugar (α-O-α-rhamnose) and 4 with two sugars [α-O-α-rhamnosyl(4→1)β-glucose]
showed a decrease in PIECmin from 4 to 2.75 μM, in right ventricular muscles. Substitution
of the C-18 CH3 of 11 with CH2OH in 14 increased PIECmin in atria from 0.05 to 0.1 μM,
but PIECmin in right ventricular muscle remained at 0.25 μM (Table 3). Similarly, changing
the C-18 CHO of 23 to COOH in 5 increased PIECmin from 0.25 μM to 0.42 μM in atria and
from 0.25 μM to 1.33 μM in right ventricular muscle. Finally, glycosylation of the
carboxylic acid increased PIECmin in atria from 0.42 μM (5, COOH) to 1.42 μM (6,
COOglc).
To confirm that, like digitalis, 23 exerts an inotropic effect through inhibition of Na+/K+
ATPase, sodium pump current (Ipump) was measured by the whole-cell patch clamp
technique. Ipump currents before and after 23 treatment were recorded. Figure 1 shows basal
Ipump (filled square), Ipump with 23 at 1 μM (filled triangle) and Ipump with 23 at 3 μM (filled
circle). Compound 23 inhibited sodium pump current in a concentration-dependent manner.
A detailed mechanistic study of the inotropic effect of 23 in guinea pig has been reported.20
Several noteworthy conclusions were obtained from this study. Nine new cardiac glycosides
(1–9) and one aglycone (10), together with eighteen known cardiac glycosides/aglycones,
were isolated from A. toxicaria. The first compounds with COOH (5, 7, 8) and COOglc (6)
from this plant were reported. These groups are representative units for the metabolic
pathway of cardiac glycosides. A side-by-side evaluation of biological activity properties of
the isolated cardiac glycosides provided additional insights into the pharmacological profile
of this compound class. Our data showed that α-O-α-rhamnosyl(4→1)-β-glucose linked at
the C-3 OH resulted in better PIECmin in right ventricular muscle. The presence of -CH3 at
C-10 was better than -CH2OH, -CHO, and -COOH, as measured by PIECmin, in atria and
right ventricular muscle. Increasing the polarity of this substituent may be beneficial in
cardiac glycosides. Most significantly, 23 increased contractility and inhibited sodium pump
current in guinea pig heart preparations in a concentration-dependent manner, and the safety
indexes of 2, 13, and 23 were better than those of ouabain in vitro.
Experimental Section
General Experimental Procedures
Proton NMR spectra were recorded on Bruker Avance 300 (300 MHz) and AMX 400 (400
MHz) spectrometers. The chemical shifts (ppm) were measured with tetramethylsilane
(TMS) as internal standard and deuterated pyridine as solvent. Mass spectra were performed
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in the EI mode on a VG 70-250S spectrometer. The optical rotation was recorded on JASCO
DIP-370 polarimeter. Merck silica gel 60 (Merck 70–230, 230–400 mesh) was used for
column chromatography. Glass sheets of silica gel 60 F254 (Merck 0.2 mm thick) were used
for TLC. Melting points were measured on a Yanagimoto MP-S3 micromelting point
apparatus and are uncorrected. The UV spectra were recorded on a Hitachi UV-3210
spectrophotometer and IR spectra were determined as KBr discs on a Shimazu FTIR-8501
spectrophotometer.
Plant Material
Trunk bark of A. toxicaria was collected from Yunnan, China, and authenticated by C. S.
Kuoh (Department of Life Sciences, National Cheng Kung University, Tainan, Taiwan). A
voucher specimen (NCKUWu 92012) has been deposited in the Herbarium of National
Cheng Kung University, Tainan, Taiwan, R.O.C.
Extraction and Isolation
The trunk bark of A. toxicaria (6.0 kg) was cut into small pieces and extracted with 95%
EtOH (20 L × 3). Evaporation of the solvent under reduced pressure provided 239.0 g of
crude extract, which was partitioned between CHCl3-H2O, and n-BuOH-H2O, successively
to yield CHCl3 (65.1 g), n-BuOH (100.2 g), and H2O (73.7 g) fractions. The CHCl3 fraction
was subjected to silica gel CC using increasing polarity mixtures of n-hexane-acetone as
eluant to give 14 fractions. Fraction 6 was chromatographed on silica gel using diisopropyl
ether-MeOH (40:1) to obtain 10 (8.7 mg), and 16 (103.2 mg). Fraction 7 was
chromatographed on silica gel and eluted with CHCl3-MeOH (15:1) to give 13 (6.6 mg), and
18 (7.0 mg). Fraction 8 was chromatographed on silica gel using EtOAc-MeOH (20:1) to
obtain 5 (37.6 mg), 15 (3.2 mg), and 27 (8.8 mg), successively. Fraction 9 was
chromatographed on silica gel using EtOAc-MeOH (20:1) to afford 23 (21.4 mg). Fraction
10 was chromatographed on silica gel using EtOAc-MeOH (20:1) to yield 17 (117.2 mg).
The n-BuOH fraction was subjected to Diaion HP-20 CC eluting with a H2O-MeOH
gradient system to give 12 fractions. Fraction 5 was chromatographed on silica gel using
CHCl3-MeOH (9:1) to obtain 7 (34.7 mg), 8 (147.4 mg), 9 (1.5 mg), 24 (58.9 mg), 25 (11.0
mg), 26 (4.3 mg), and 28 (7.3 mg), successively. Fraction 6 was chromatographed on silica
gel using CHCl3-MeOH (9:1) to obtain 25 (118.4 mg). Fraction 7 was chromatographed on
silica gel using CHCl3-MeOH-H2O (9:1:0.05) to obtain 21 (11.4 mg). Fraction 8 was
chromatographed on silica gel using CHCl3-MeOH-H2O (9:1:0.05) to afford 2 (12.3 mg), 3
(112.3 mg), 4 (12.2 mg), 6 (5.9 mg), 12 (9.1 mg), 14 (6.1 mg), 17 (431.2 mg), 18 (4.3 mg),
20 (5.9 mg), 21 (79.8 mg), and 22 (18.3 mg). Fraction 9 was chromatographed on silica gel
using CHCl3-MeOH-H2O (9:1:0.05) to obtain 11 (7.6 mg), 17 (12.5 mg), 19 (19.7 mg), and
20 (14.3 mg). Fraction 10 was chromatographed on silica gel using CHCl3-MeOH-H2O
(9:1:0.05) to obtain 1 (9.8 mg), 11 (3.3 mg), 19 (10.2 mg), 20 (3.5 mg), and 27 (13.5 mg).
The water fraction was directly subjected to Diaion HP-20 CC eluting with water containing
increasing proportions of MeOH to give twelve fractions. Fraction 8 was chromatographed
on a Sephadex LH-20 column using mixtures of MeOH-H2O of increasing polarity to obtain
25 (20.2 mg), and 26 (1.3 mg). Fraction 9 was chromatographed on Sephadex LH-20 eluting
with water containing increasing proportions of MeOH to give 4 (26.4 mg), 17 (43.2 mg),
and 21 (26.8 mg).
Antiaroside A (1): colorless needles (CHCl3-MeOH); mp 184–186 °C; [α]25 D −24.4 (c
0.09, MeOH); UV (MeOH) λmax (log ε) 213 (4.67) nm; IR (KBr) υmax 3450, 2939, 1738,
1622, 1450, 1383, 1078, 1038 cm−1; 1H and 13C NMR data, see Tables 1 and 2; FABMS m/
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z 559 [M+23]+ (16), 537 (47), 391 (29), 373 (43), 355 (100), 337 (54), 277 (47), 185 (98);
HRFABMS m/z 537.3063 [M + 1]+ (calcd for C29H45O9, 537.3064).
Antiaroside B (2): colorless syrup; [α]25 D −20.09 (c 0.12, MeOH); UV (MeOH) λmax (log
ε) 218 (4.32) nm; IR (KBr) υmax 3400, 2936, 1738, 1730, 1655, 1067, 1030 cm−1; 1H
and 13C NMR data, see Tables 1 and 2; FABMS m/z 737 [M + 39]+ (3), 721 [M + 23]+ (3),
699 (2), 519 (3), 356 (5), 185 (100), 147 (25); HRFABMS m/z 737.8260 [M + 39]+ (calcd
for C35H54KO14 737.8262).
Antiaroside C (3): colorless powder (CHCl3-MeOH); mp 231–232 °C; [α]25 D −11.31 (c
1.03, MeOH); UV (MeOH) λmax (log ε) 213 (4.17) nm; IR (KBr) υmax 3440, 2934, 1734,
1715, 1618, 1454, 1344, 1198, 1057 cm−1; 1H and 13C NMR data, see Tables 1 and 2;
FABMS m/z 551 [M + 1]+ (25), 405 (13), 387 (35), 369 (36), 351 (18), 341 (22), 323 (26),
185 (100), 179 (12), 147 (54); HRFABMS m/z 551.2855 [M + 1]+ (calcd for C29H43O10,
551.2856).
Antiaroside D (4): colorless syrup; [α]25 D −21.73 (c 0.39, MeOH); UV (MeOH) λmax (log
ε) 213 (4.37) nm; IR (KBr) υmax 3400, 2932, 1734, 1647, 1456, 1067, 1030 cm−1; 1H
and 13C NMR data, see Tables 1 and 2; FABMS m/z 751 [M + 39]+ (7), 549 (2), 403 (6),
387 (6), 369 (6), 359 (4), 342 (6), 341 (8), 323 (12), 207 (16), 185 (100), 179 (3), 163 (7),
147 (19); HRFABMS m/z 751.2943 [M + 39]+ (calcd for C35H52KO15, 751.2943).
Antiaroside E (5): colorless syrup; [α]25 D −29.07 (c 0.25, MeOH); UV (MeOH) λmax (log
ε) 216 (4.40) nm; IR (KBr) υmax 3460, 2936, 1738, 1670, 1453, 1076, 1036 cm−1; 1H
and 13C NMR data, see Tables 1 and 2; FABMS m/z 551 [M + 1]+ (30), 507 (10), 462 (17),
417 (38), 387 (23), 359 (15), 341 (26), 323 (35), 315 (57), 277 (25), 185 (100), 147 (63);
HRFABMS m/z551.2856 [M + 1]+ (calcd for C29H43O10, 551.2856).
Antiaroside F (6): colorless syrup; [α]25 D −19.61 (c 0.06, MeOH); UV (MeOH) λmax (log
ε) 216 (4.42) nm; IR (KBr) υmax 3400, 1726, 1655, 1647, 1642, 1545, 1533, 1460 cm−1; 1H
and 13C NMR data, see Tables 1 and 2; FABMS m/z 751 [M + 39]+ (7), 713 (3), 550 (3),
534 (2), 490 (3), 241 (6), 185 (100), 147 (6); HRFABMS m/z 751.2943 [M + 39]+ (calcd for
C35H53O15, 751.2945).
Antiaroside G (7): colorless syrup; [α]25 D +3.07 (c 0.3472, MeOH); UV (MeOH) λmax (log
ε) 218 (4.67) nm; IR (KBr) υmax 3440, 2941, 1738, 1726, 1514, 1036 cm−1; 1H and 13C
NMR data, see Tables 1 and 2; FABMS m/z 583 [M + 1]+ (11), 437 (6), 383 (3), 277 (9),
241 (7), 207 (9), 185 (100), 149 (18), 147 (6), 115 (116); HRFABMS m/z 583.2752 [M +
1]+ (calcd for C29H43O12, 583.2754).
Antiaroside H (8): colorless syrup; [α]25 D +0.77 (c 1.47, MeOH); UV (MeOH) λmax (log ε)
219 (4.20) nm; IR (KBr) υmax 3420, 2970, 2941, 2878, 1739, 1710, 1618, 1450, 1416, 1377,
1313, 1030, 993 cm−1; 1H and 13C NMR data, see Tables 1 and 2; FABMS m/z 583 [M +
1]+ (21), 437 (25), 401 (8), 383 (10), 337 (11), 185 (100), 147 (28), 129 (33); HRFABMS m/
z 583.2753 [M + 1]+ (calcd for C29H43O12, 583.2754).
Antiaroside I (9): colorless syrup; [α]25 D −28.22 (c 0.08, MeOH); UV (MeOH) λmax (log
ε) 217 (4.17) nm; IR (KBr) υmax 3430, 2934, 1742, 1647, 1454, 1364, 1225, 1049, 987
cm−1; 1H and 13C NMR data, see Tables 1 and 2; FABMS m/z 523 [M + 1]+ (28), 360 (11),
359 (25), 341 (30), 323 (14), 225 (39), 185 (100), 147 (27), 131 (56), 129 (36); HRFABMS
m/z 523.2908 [M + 1]+ (calcd for C28H43O9, 523.2907).
Antiarotoxinin A (10): colorless powder; [α]25 D +30.96 (c 0.087, MeOH); UV (MeOH)
λmax (log ε) 212 (3.95) nm; IR (KBr) υmax 3304, 2943, 1761, 1643, 1275, 1036 cm−1; 1H
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and 13C NMR data, see Tables 1 and 2; EIMS m/z 408 (M+, 2), 390 (9), 372 (25), 354 (26),
318 (100), 219 (29), 201 (43), 145 (21), 124 (39), 121 (28), 111 (37), 109 (26), 107 (36), 93
(40), 91 (46), 81 (55), 55 (60); HREIMS m/z 408.2513 [M]+ (calcd for C23H36O6,
408.2511).
Assay Methods of Positive Inotropic Action and Arrhythmogenic Action
Adult guinea pigs (300–500 g) were anesthetized with pentobarbital (25 mg/kg, i.p.). The
heart was excised, and retrograde coronary perfusion was performed with normal Tyrode’s
solution containing (in mM) NaCl 137, KCl 5.4, CaCl2 2, MgCl2 1.1, NaH2PO4 0.33,
NaHCO3 11.9 and glucose 11 through coronary artery. Tyrode’s solution was maintained at
37 °C and continuously aerated with 95% O2 + 5% CO2 (pH 7.2–7.4 under these
conditions). Left atria and right ventricular muscles were separated from the heart. One end
of the muscle was attached to a rigid support and the other end was attached to a transducer
in the 10 mL bath. Each tissue was placed under 1 g tension and stimulated at 2 Hz, with
pulses of 2 ms duration and amplitude twice the threshold. Following stabilization for about
60 min, drugs were cumulatively added. The positive inotropic effects (PIEmax) and safety
indexes were studied according to the methods described previously.20,21 Briefly, the
minimal positive inotropic effective concentration (PIECmin) to increase myocardial
contraction and the arrhthymogenic concentration to induce arrhythmia in these isolated
cardiac preparations were measured. The maximal positive inotropic effect was determined
at a concentration level immediately before the occurrence of cardiac arrhythmia and the
safety index was then measured from the ratio of arrhthymogenic concentration to minimal
effective positively inotropic concentration.
Electrophysiological Recording of Malayoside (23)
Cardiomyocytes were isolated by using the enzymatic method previously described.20 Adult
male guinea pigs (200–250 g) were intraperitoneally injected with sodium pentobarbital (25
mg/kg) plus heparin (16 mg/kg). After the guinea pig was deeply anesthetized, heart was
excised and the coronary artery was antegradely perfused with oxygenated Ca2+-free
HEPES solution containing (in mM) 137 NaCl, 22 glucose, 6 HEPES, 1.2 MgSO4, 1.2
KH2PO4, and 5.4 KCl; pH was adjusted to 7.4 using NaOH. The heart was then perfused
with the same solution containing 0.4 mg/mL collagenase (type II, Sigma Chemical Co., St.
Louis, Mo, USA), 0.06 mg/mL protease (type XIV, Sigma) and bovine serum albumin 1 mg/
mL.
After 4–5 min of digestion, enzymes were washed out in Kruftbruhe solution containing (in
mM) 10 taurine, 10 oxylate, 70 glutamate, 25 KCl, 10 KH2PO4, 11 glucose, 0.5 EGTA; pH
was adjusted to 7.4 using KOH. The ventricles were then chopped and resuspended under
gentle mechanical agitation and stored in Kruftbruhe solution at room temperature.
The whole-cell patch clamp technique was used to record ionic currents in voltage clamp
mode with a Dagan 8900 voltage clamp amplifier (Dagan Co., Minneapolis, Minn., U.S.A.).
A droplet of the cell suspension was placed in a chamber mounted on the stage of an
inverted microscope (Nikon, Diaphot, Japan). After settling down, cells were finally
exposed to the bath solution containing (in mM) 137 NaCl, 5.4 KCl, 2.9 MgCl2, 6 HEPES,
22 glucose, 0.33 NaH2PO4, 2 BaCl2, and 0.2 CdCl; pH was adjusted to 7.4 using NaOH. For
the measurement of Ipump, a pipette was filled with the internal solution containing (mM) 80
CsOH, 50 NaOH, 3 MgCl2, 20 TEA-Cl, 100 aspartic acid, 10 HEPES, 10 ATP-Mg, 0.2
GTP-Na3, 5.5 glucose, 5 Na-creatine phosphate, and 5 pyruvic acid; pH was adjusted to 7.2
using CsOH. Heat-polished glass electrodes (tip resistances about 1 MΩ when filled with
pipette internal solution) were used. After rupture of the patch, the holding potential was set
at −40 mV to inactivate Na+ channels and the cell interior was allowed to equilibrate 5 min
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with the pipette solution. Then membrane currents were elicited by voltage ramps from +60
mV to −120 mV. Junction potentials were zeroed before the formation of the membrane–
pipette seal in bath solution. The series resistance was electronically compensated by about
80% to minimize the duration of the capacitive surge on the current recorded and the voltage
drop across the pipette. Currents were elicited and acquired using Digidata 1200 data
acquisition system controlled using pClamp software (Axon Instruments). Recordings were
lowpass filtered at 10 kHz and stored on the hard disk of a computer.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Drug effects on Ipump of basal (filled square), 23 at 1 μM (filled triangle) and 3 μM (filled
circle) treated cells.
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Table 2
1H NMR Data of Compounds Isolated from A. toxicaria.
Proton 1 2
1a/b 1.44 (m)/2.19 (dd, 14.2, 2.9) 1.66 (br. t, 4.1)/2.33 (ddd, 13.5, 13.5, 3.1)
2a/b 1.79 (m)/2.02 (br. d, 13.0) 1.72 (m)/1.89 (m)
3 4.51 (br. s, 10.7) † 4.15 (br. s, 13.6) †
4a/b 1.88 (m)/2.15 (dd, 15.2, 2.9) 1.25 (br. d, 12.8)/2.01 (m)
5 2.55 (br. d, 13.3)
6a/b 1.54 (m)/1.95 (m) 1.57 (m)/1.89 (m)
7a/b 1.33 (m)/2.23 (br. d, 11.7) 1.43 (m)/2.14 (m)
8 1.83 (m) 2.01 (m)
9 1.67 (br. t, 11.4) 1.89 (m)
10
11a/b 1.38 (br. d, 10.0)/1.44 (m) 1.43 (m)
12a/b 1.44 (m) 1.48 (m)
15a/b 1.88 (m)/2.08 (m) 1.89 (m)/2.17 (br. dd, 10.4, 10.4)
16a/b 1.95 (m)/2.08 (m) 2.01 (m)/2.14 (m)
17 2.81 (dd, 8.8, 5.0) 2.81 (dd, 9.0, 5.1)
18 1.03 (s) 1.04 (s)
19a/b 1.08 (s) 3.77 (dd, 10.9, 5.5)/4.07 (d, 10.9)
21a/b 5.01 (dd, 18.0, 1.3)/5.28 (dd, 18.0, 1.3) 5.01 (d, 18.0)/5.29 (d, 18.0)
22 6.12 (s) 6.12 (s)
1′ 5.37 (d, 8.1) 5.37 (br. s)
2′ 4.45 (dd, 8.1, 2.9) 4.49 (br. s)
3′ 4.71 (d, 2.9) 4.62 (dd, 9.1, 2.1)
4′ 4.10 (br. s) 4.34 (d, 9.1)
5′ 4.58 (q, 6.4) 4.29 (dq, 9.1, 6.0)
6′ 1.56 (d, 6.4) 1.70 (d, 6.0)
1″ 5.18 (d, 7.7)
2″ 4.05 (d, 7.7)
3″ 4.18 (d, 9.1)
4″ 4.21 (d, 9.1)
5″ 3.79 (m)
6″a/b 4.39 (m)/4.43 (m)
Proton 3 4
1a/b 2.07 (m)/2.34 (dd, 10.1, 4.2) 2.03 (m)/2.32 (m)
2a/b 1.61 (m)/2.29 (m) 1.57 (ddd, 13.4, 13.4, 4.3)/2.28 (m)
3 4.66 (dddd, 11.2, 11.2, 5.0, 4.3) 4.60 (dddd, 10.4, 10.4, 5.1, 5.1)
4a/b 1.78 (br. d, 13.6)/2.42 (dd, 13.6, 4.3) 1.72 (m)/2.39 (dd, 13.5, 5.1)
5
6a/b 1.68 (m)/2.22 (m) 1.63 (m)/1.77 (m)
7a/b 1.68 (m)/2.29 (m) 2.11 (br. dd, 8.0, 3.7)/2.28 (m)
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Proton 1 2
8 2.22 (m) 2.16 (ddd, 13.7, 13.7, 4.3)
9 1.40 (m) 2.23 (m)
10
11a/b 1.40 (m)/1.68 (m) 1.43 (m)/1.68 (br. d, 10.2)
12a/b 1.40 (m) 1.41 (m)/1.27 (dd, 14.3, 3.1)
15a/b 1.29 (dd, 13.6, 3.0)/1.83 (m) 1.41 (m)/1.85 (m)
16a/b 2.13 (m)/1.91 (m) 2.05 (ddd, 13.5, 3.5, 3.4)/1.90 (ddd, 13.5, 9.0, 4.8)
17 2.02 (dd, 8.8, 4.8) 1.99 (m)
18 2.73 (dd, 9.3, 4.8) 2.74 (ddd, 9.0, 4.8)
19a/b 0.95 (s)/10.12 (s) 0.96 (s)/0.13 (s)
21a/b 4.98 (dd, 18.0, 1.3)/5.25 (dd, 18.0, 1.3) 4.97 (dd, 18.0, 1.4)/5.25 (dd, 18.0, 1.4)
22 6.09 (s) 6.09 (s)
1′ 5.36 (br. s) 5.30 (br. s)
2′ 4.43 (br. s) 4.40 (br. s)
3′ 4.44 (dd, 8.6, 3.3) 4.54 (d, 10.1)
4′ 4.21 (m) 4.32 (dd, 10.1, 9.3)
5′ 4.26 (dq, 8.6, 5.8) 4.18 (m)
6′ 1.59 (d, 5.8) 1.63 (d, 6.1)
1″ 5.20 (d, 7.7)
2″ 4.08 (dd, 8.1, 7.7)
3″ 4.18 (m)
4″ 4.18 (m)
5″ 3.78 (ddd, 8.4, 4.5, 4.5)
6″a/b 4.34 (m)/4.42 (m)
Proton 5 6
1a/b 1.60 (ddd, 12.6, 12.6, 3.1)/2.51 (m) 1.55 (ddd, 14.0, 10.0, 2.6)/2.37 (ddd, 12.9, 12.9, 3.8)
2a/b 1.99 (m)/2.54 (m) 1.64 (m)/1.91 (m)
3 4.52 (br. s, 12.4) † 4.17 (br. s, 10.7) †
4a/b 1.38 (m)/1.99 (m) 2.00 (m)/2.64 (dd, 14.0, 3.3)
5 2.92 (br. d, 12.6) 2.88 (br. d, 11.9)
6a/b 1.70 (m)/1.97 (m) 1.64 (m)/1.86 (m)
7a/b 1.67 (m)/1.91 (m) 1.41 (m)/2.07 (m)
8 2.59 (m) 2.52 (ddd, 11.7, 11.7, 2.4)
9 1.91 (m) 1.91 (m)
10
11a/b 1.42 (dd, 129, 12.9)/2.17 (m) 1.20 (m)/2.00 (m)
12a/b 1.48 (m) 1.41 (m)
15a/b 1.87 (m)/2.11 (m) 1.86 (m)/2.12 (m)
16a/b 2.06 (m) 2.00 (m)/2.12 (m)
17 2.84 (dd, 8.3, 4.2) 2.79 (br. dd, 8.4, 5.2)
18 1.20 (s) 1.17 (s)
19
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Proton 1 2
21a/b 5.06 (d, 18.0)/5.35 (d, 18.0) 5.00 (d, 18.1)/5.28 (d, 18.1)
22 6.14 (s) 6.10 (s)
1′ 5.48 (br. s) 5.39 (br. s)
2′ 4.57 (br. s) 4.46 (m)
3′ 4.52 (d, 8.2) 4.46 (m)
4′ 4.32 (m) 4.22 (m)
5′ 4.32 (m) 4.30 (dq, 6.0, 6.0)
6′ 1.67 (d, 5.1) 1.65 (d, 6.0)
1″ 6.29 (d, 8.0)
2″ 4.13 (dd, 8.0, 7.7)
3″ 4.22 (m)
4″ 4.22 (m)
5″ 4.01 (br. dd, 7.1, 4.0)
6″a/b 4.31 (dd, 5.9, 3.4)/4.38 (d, 11.3)
Proton 7‡ 8‡
1a/b 2.27 (br. d, 14.7)/2.97 (br. d, 14.7) 2.28 (d, 16.4)/3.16 (dd, 14.7, 14.7)
2a/b 1.78 (br. d, 14.1)/1.98 (m) 1.87 (m)/2.16 (m)
3 4.35 (br. s, 9.3) † 4.51 (br. s, 12.1) †
4a/b 1.87 (br. d, 14.5)/1.98 (m) 2.00 (m)/2.16 (m)
5
6a/b 1.65 (m)/3.13 (br. d, 13.1) 1.69 (br. d, 12.6)/3.11 (m)
7a/b 1.48 (m)/2.49 (d, 12.7) 1.47 (br. d, 13.4)/2.48 (br. d, 11.9)
8 3.06 (br. d, 10.1) 3.04 (m)
9 2.19 (m) 2.00 (m)
10
11a/b 1.98 (m)/2.39 (dd, 7.4, 3.7) 2.00 (m)
12a/b -/3.81 (br. d, 10.8) -/3.77 (br. d, 6.9)
15a/b 1.98 (m)/1.98 (m) 2.00 (m)/2.35 (m)
16a 2.16 (m) 2.16 (m)
17 3.75 (t, 7.5) 3.75 (t, 7.9)
18 1.26 (s) 1.26 (s)
19
21a/b 5.13 (d, 18.1)/5.29 (d, 18.1) 5.12 (d, 18.1)/5.28 (d, 18.1)
22 6.24 (s) 6.25 (s)
1′ 5.54 (br. s) 5.44 (d, 8.1)
2′ 4.53 (br. s) 4.49 (dd, 8.1, 2.6)
3′ 4.46 (br. d, 4.7) 4.76 (br. s)
4′ 4.29 (m) 4.14 (d, 3.0)
5′ 4.27 (br. q, 3.7) 4.62 (q, 6.2)
6′ 1.65 (d, 3.7) 1.56 (d, 6.2)
1″
2″




















1a/b 1.38 (br. d, 13.8)/2.19 (br. d, 17.0) 1.48 (m)/2.24 (m)
2a/b 1.65 (m)/2.00 (m) 1.82 (m)
3 4.22 (br. s, 9.1) † 4.44 (br. s, 12.8) †
4a/b 1.79 (m)/2.10 (m) 1.78 (d, 10.1)/2.29 (d, 14.6)
6a/b 1.79 (m)/2.10 (m) 1.62 (br. d, 13.0)/1.96 (dt, 9.1, 4.0)
7a/b 1.26 (m)/2.41 (br. d, 7.9) 2.24 (m)
8 2.43 (br. d, 11.5) 1.97 (dt, 9.1, 4.0)
9 2.31 (br. d, 12.5) 1.70 (br. t, 10.7)
10 1.83 (d, 12.5)
11a/b 1.06 (br. d, 12.0)/1.90 (m) 1.45 (ddd, 10.6, 9.6, 4.0)
12a/b 1.44 (m) 1.36 (dt, 13.3, 10.6)/1.48 (dt, 13.3, 9.6)
15a/b 1.90 (m)/2.10 (m) 1.84 (m)/2.04 (m)
16 2.00 (m) 2.04 (m)
17 2.10 (m) 2.14 (dd, 8.2, 5.7)
18 2.79 (br. d, 7.8) 1.27 (s)
19 1.06 (s) 1.17 (s)
21a/b 5.03 (d, 18.1)/5.33 (d, 18.1) 4.40 (d, 9.4)/4.78 (d, 9.4)
22 6.12 (s) 2.82 (d, 16.8)/2.86 (d, 16.8)












δ value in pyridine-d5 (400 MHz), coupling constants in Hz are given in parentheses.
†
W1/2 (Hz): width of 1/2 peak high.
‡
δ value in pyridine-d5 (300 MHz), coupling constants in Hz are given in parentheses.
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Table 3
Minimal Positive Inotropic Effectctive Concentration (PIECmin) of Cardiac Glycosides in Atria and
Ventricular Strips.
Left atria strips Right ventricular strips
Cmpd PIECmin (μM) Cmpd PIECmin (μM)
1 0.10±0.07 1 0.083±0.03
2 0.38±0.13 2 0.075±0.05
3 2.75±0.25 3 4±1
4 2.75±0.25 4 2.75±0.25
5 0.42±0.08 5 1.33±0.6
6 1.42±0.58 6 3.17±0.93
7 3.75±1.25 7 3.67±1.33
8 7.50±2.50 8 8.33±1.67
9 0.83±0.17 9 0.67±0.17
10 0.1 10 -
11 0.05±0.01 11 0.25±0.1
12 0.1 12 0.25
13 1.25±0.75 13 0.30±0.20
14 0.1 14 0.25
16 1 16 4.8±1.5
17 0.1 17 0.125
18 0.25 18 1
19 0.05 19 0.5
20 0.5 20 0.5
21 0.25 21 1
22 0.25 22 1
23 0.25 23 0.25
24 0.05 24 -
25 0.5 25 2
26 0.25 26 -
27 0.1 27 -
28 1 28 2
Ouabain 0.05 Ouabain 0.05
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Table 4
Maximal Positive Inotropic Effect (PIEmax) of Cardiac Glycosides in Atria and Ventricular Strips.
Left atria strips Right ventricular strips
Cmpd PIEmax (% of basal) Cmpd PIEmax (% of basal)
1 158±28 1 165±33
2 373±187 2 382±99
3 208±34 3 229±35
4 201±1 4 369±47
5 264±38 5 230±19
6 140±28 6 618±321
7 419±31 7 221±69
8 144±27 8 260±33
9 562±236 9 1246±49
10 367 10 -
11 381±104 11 355±33
12 278 12 150
13 205±5 13 408±128
14 138 14 625
16 165±15 16 240±74
17 467 17 300
18 567 18 200
19 300 19 300
20 225 20 350
21 443±105 21 292±17
22 489 22 350
23 660±88 23 464±89
24 121 24 -
25 220 25 200
26 350 26 -
27 163 27 -
28 243 28 250
Ouabain 775±128 Ouabain 249±26
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Table 5
Safety Index of Cardiac Glycosides in Atria and Ventricular Strips.
Left atria strips Right ventricular strips
Cmpd Safety index Cmpd Safety index
1 4.3±0.3 1 18±11.1
2 5.0±1.0 2 100±60
3 15 3 9.7±3.7
4 7.3±0.7 4 6.3±0.3
5 10 5 7.7±3.5
6 6.0±2.3 6 5.8±1.0
7 13±1 7 20.7±10
8 7.5±2.5 8 9.7±3.3
9 6.7±1.7 9 10.7±1.8
10 1000 10 -
11 11±3.7 11 8.8±3.3
12 10 12 2
13 6.3±3.8 13 65±25
14 5 14 20
16 9 16 8.7±3.0
17 10 17 8
18 10 18 5
19 50 19 10
20 2.5 20 4
21 20 21 9
22 10 22 10
23 20 23 24
24 20 24 -
25 10 25 15
26 80 26 -
27 10 27 -
28 10 28 15
Ouabain 20 Ouabain 20
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